Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Urotensin II and Vascular Tone in Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00163995
Recruitment Status : Unknown
Verified September 2005 by Bayside Health.
Recruitment status was:  Recruiting
First Posted : September 14, 2005
Last Update Posted : July 26, 2007
Sponsor:
Information provided by:
Bayside Health

Brief Summary:
This study looks at the iontophoresis of urotensin II in chronic liver disease patients.

Condition or disease Intervention/treatment
Liver Diseases Cirrhosis Drug: urotensin II

Layout table for study information
Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Liver Diseases





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Cirrhosis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00163995


Contacts
Layout table for location contacts
Contact: William W Kemp, MBBS, FRACP 92762000 ext 3327 w.kemp@alfred.org.au

Locations
Layout table for location information
Australia, Victoria
Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3181
Contact: William W Kemp, MBBS, FRACP    92762000 ext 3327    w.kemp@alfred.org.au   
Sponsors and Collaborators
Bayside Health
Investigators
Layout table for investigator information
Principal Investigator: William W Kemp, MBBS, FRACP The Alfred
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00163995    
Other Study ID Numbers: AH4004
First Posted: September 14, 2005    Key Record Dates
Last Update Posted: July 26, 2007
Last Verified: September 2005
Keywords provided by Bayside Health:
Chronic Liver Disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Liver Cirrhosis
Liver Diseases
Fibrosis
Pathologic Processes
Digestive System Diseases